Andrew Stolz

7.2k total citations · 1 hit paper
97 papers, 3.6k citations indexed

About

Andrew Stolz is a scholar working on Pharmacology, Oncology and Epidemiology. According to data from OpenAlex, Andrew Stolz has authored 97 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pharmacology, 30 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Andrew Stolz's work include Drug-Induced Hepatotoxicity and Protection (37 papers), Drug Transport and Resistance Mechanisms (29 papers) and Pharmacogenetics and Drug Metabolism (26 papers). Andrew Stolz is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (37 papers), Drug Transport and Resistance Mechanisms (29 papers) and Pharmacogenetics and Drug Metabolism (26 papers). Andrew Stolz collaborates with scholars based in United States, United Kingdom and Japan. Andrew Stolz's co-authors include Robert J. Fontana, Neil Kaplowitz, Huiman X. Barnhart, Hajime Takikawa, Paul H. Hayashi, K. Rajender Reddy, José Serrano, David E. Kleiner, Victor J. Navarro and Jay H. Hoofnagle and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew Stolz

90 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network

2014 292 citations Victor J. Navarro, Huiman X. Barnhart et al. Hepatology profile →

Peers

Countries citing papers authored by Andrew Stolz

Since Specialization

Citations

This map shows the geographic impact of Andrew Stolz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Stolz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Stolz more than expected).

Fields of papers citing papers by Andrew Stolz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Stolz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Stolz. The network helps show where Andrew Stolz may publish in the future.

Co-authorship network of co-authors of Andrew Stolz

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Stolz. A scholar is included among the top collaborators of Andrew Stolz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Stolz. Andrew Stolz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical characteristics and HLA associations of azithromycin‐induced liver injury 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), Yi‐Ju Li, Jawad Ahmad, Huiman X. Barnhart, Robert J. Fontana, Marwan Ghabril, Paul H. Hayashi, David E. Kleiner, William M. Lee, Vı́ctor Navarro, Joseph A. Odin, Elizabeth J. Phillips, Andrew Stolz, Raj Vuppalanchi, Dina Halegoua‐DeMarzio, (unknown)	7
2	Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database 2024 ·The American Journal of Gastroenterology ·(unknown), Paul H. Hayashi, Andrew Stolz, Huiman X. Barnhart, Jay H. Hoofnagle, (unknown)	3
3	Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning 2024 ·SHILAP Revista de lepidopterología ·(unknown), Chr̀istophe Magnan, (unknown), (unknown), Andrew Stolz, John A. Tayek, Zhang‐Xu Liu, Jon Jacobs, Timothy R. Morgan, Trina M. Norden‐Krichmar	4
4	Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis 2022 ·American Journal Of Pathology ·Josepmaria Argemí, (unknown), Marina Gritsenko, Ana Clemente, (unknown), José M. Herranz, Zhang‐Xu Liu, Stephen R. Atkinson, Richard Smith, Trina M. Norden‐Krichmar, (unknown), Andrew Stolz, John A. Tayek, Ramón Bataller, Timothy R. Morgan, Jon Jacobs	8
5	Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate 2022 ·Gastroenterology ·Paola Nicoletti, Andrew Dellinger, Yi‐Ju Li, Huiman X. Barnhart, Naga Chalasani, Robert J. Fontana, Joseph A. Odin, José Serrano, Andrew Stolz, Amy S. Etheridge, Federico Innocenti, Olivier Govaere, Jane I. Grove, Camilla Stephens, Guruprasad P. Aithal, Raúl J. Andrade, Einar S. Björnsson, Ann K. Daly, M. Isabel Lucena, Paul B. Watkins	25
6	Newly identified genetic variants associated with idiosyncratic drug-induced liver injury 2022 ·Current Opinion in Gastroenterology ·Andrew Stolz	6
7	Inhibition of Estrogen-Related Receptor α Blocks Liver Steatosis and Steatohepatitis and Attenuates Triglyceride Biosynthesis 2021 ·American Journal Of Pathology ·Chien-Yu Chen, Yang Li, Ni Zeng, Lina He, Xinwen Zhang, (unknown), Qi Tang, (unknown), (unknown), (unknown), (unknown), Enrique Cadenas, Andrew Stolz, Gang Li, Bangyan L. Stiles	21
8	Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis 2019 ·Hepatology International ·(unknown), Natasha Kamal, Christopher Koh, Niharika Samala, Robert J. Fontana, Andrew Stolz, Francisco Durazo, Paul H. Hayashi, Elizabeth J. Phillips, (unknown), Jay H. Hoofnagle	36
9	Liver injury from nonsteroidal anti‐inflammatory drugs in the United States 2015 ·Liver International ·Paul A. Schmeltzer, Andrzej S. Kosinski, David E. Kleiner, Jay H. Hoofnagle, Andrew Stolz, Robert J. Fontana, Mark W. Russo, (unknown)	67
10	Clinical and histologic features of azithromycin-induced liver injury 2015 ·Carolina Digital Repository (University of North Carolina at Chapel Hill) ·Melissa Martínez, Raj Vuppalanchi, Robert J. Fontana, Andrew Stolz, David E. Kleiner, Paul H. Hayashi, Jiezhun Gu, Jay H. Hoofnagle, Naga Chalasani	7
11	Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network breakdown → 2014 ·Hepatology ·Victor J. Navarro, Huiman X. Barnhart, Herbert L. Bonkovsky, Timothy J. Davern, Robert J. Fontana, Lafaine Grant, K. Rajender Reddy, Leonard B. Seeff, José Serrano, Averell H. Sherker, Andrew Stolz, Jayant A. Talwalkar, Maricruz Vega, Raj Vuppalanchi	292
12	Clinical and Histologic Features of Azithromycin-Induced Liver Injury 2014 ·Clinical Gastroenterology and Hepatology ·Melissa Martínez, Raj Vuppalanchi, Robert J. Fontana, Andrew Stolz, David E. Kleiner, Paul H. Hayashi, Jiezhun Gu, Jay H. Hoofnagle, Naga Chalasani	94
13	Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling 2007 ·Cancer Research ·Qing Ji, Lilly Chang, Frank Z. Stanczyk, Murad Ookhtens, Andy Sherrod, Andrew Stolz	52
14	Increasing AKR1C1 and AKR1C2 dependent DHT catabolism in prostate cancer (CaP) cell lines by Phase II Inducers can prevent DHT-dependent gene expression: implications for chemoprevention of CaP 2006 ·Cancer Research ·Andrew Stolz, Shouying Du, (unknown), Murad Ookhtens, Frank Z. Stanczyk	0
15	Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2 2006 ·Molecular Pharmacology ·Huan Lou, Shouying Du, Qing Ji, Andrew Stolz	86
16	Chelerythrine stimulates GSH transport by rat Mrp2 (Abcc2) expressed in canine kidney cells 2003 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Huan Lou, Murad Ookhtens, Andrew Stolz, Neil Kaplowitz	21
17	Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism 2003 ·The Prostate ·Qing Ji, Lilly Chang, (unknown), Frank Z. Stanczyk, Andrew Stolz	72
18	BILE ACID TRANSPORT 1999 ·Gastroenterology Clinics of North America ·Ron Bahar, Andrew Stolz	59
19	Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis 1996 ·Gastroenterology ·Carsten Gartung, Meenakshisundaram Ananthanarayanan, (unknown), Stephan Schuele, Samiran Nundy, (unknown), Andrew Stolz, (unknown), (unknown)	214
20	Oxidation and reduction of bile acid precursors by rat hepatic 3α-hydroxysteroid dehydrogenase and inhibition by bile acids and indomethacin 1990 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Hajime Takikawa, Andrew Stolz, Syoji Kuroki, Neil Kaplowitz	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact